Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Regadenoson

Regadenoson

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Regadenoson

28 trials tracked of Regadenoson: 12 in phase 3 or 4 and 2 with published results. The most-cited published study has 71 citations.

28Trials tracked
12Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 10 Phase 3 2 Phase 2 4 Phase 1 3 Other / NA 9
  1. Phase 4 Myocardial Perfusion, Oxidative Metabolism, and Fibrosis in HFpEF Completed · 71 cited
  2. Phase 4 Stress Testing and Cardiac Magnetic Resonance Completed · 45 cited
  3. Phase 4 Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging Completed
  4. Phase 4 Integrated Dual Exercise and Lexiscan Positron Emission Tomography: IDEALPET Completed
  5. Phase 4 Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle Tracking Completed
  6. Phase 4 A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease Completed
Show 22 more trials
  1. Phase 4 A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment Completed
  2. Phase 4 Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson Completed
  3. Phase 4 Characterization of Myocardial Blood Flow Measurements Using Lexiscan®™ (Regadenoson) (Lexiscan®™) Rubidium-82 Myocardial Perfusion PET: A Temporal-Dependency Investigation Completed
  4. Phase 4 Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction Completed
  5. Phase 3 A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT) Completed
  6. Phase 3 Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) Completed
  7. Phase 2 Treat COVID-19 Patients With Regadenoson Completed
  8. Phase 2 A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT) Completed
  9. Phase 2 A Phase II Trial of Regadenoson in Sickle Cell Anemia Completed
  10. Phase 2 Absolute Quantification of Coronary Flow Reserve by Stress Perfusion MRI Completed
  11. Phase 1 Comparison of Intravenous Adenosine Infusion With Regadenoson Bolus for Inducing Maximal Coronary Hyperemia Completed
  12. Phase 1 Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson Administration Completed
  13. Phase 1 Regadenoson R-T Perfusion Imaging Trial Completed
  14. N/A Multivariable Assessment of Coronary Artery Disease Using Cardiac CT Imaging Completed
  15. N/A Regadenoson Combined With Symptom-Limited Exercise in Patients Undergoing Myocardial Perfusion Imaging Completed
  16. N/A Myocardial Blood Flow by PET and N-13 Ammonia During Regadenoson vs Adenosine Stress Completed
  17. N/A Artifact-Free High-Resolution Myocardial Perfusion MRI in Subjects With Abnormal Nuclear Myocardial Perfusion Studies Completed
  18. N/A Maximal Bruce Protocol With the Use of Regadenoson For Myocardial Perfusion Stress Testing Completed
  19. N/A Heart Rate Response to Regadenoson and Sudden Cardiac Death Completed
  20. N/A The MATCH Investigation: CT Myocardial Perfusion and CT-FFR vs PET MPI Completed
  21. N/A Effects of Body Mass Index on the Hyperemic Response to Regadenoson Completed
  22. N/A Stress CT Perfusion in Patients With Chest Pain Completed

Showing the 28 most-cited and recently-updated of 28 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.